(Source: Business Wire)
Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, visited the NASDAQ MarketSite in New York City's Times Square earlier today to preside over the Opening Bell and celebrate its five year anniversary of listing on The NASDAQ Stock Market.
For an archived webcast of the NASDAQ Opening Bell and high resolution photographs of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on Phase Forward/Market Open.
Members of the media interested in speaking with Phase Forward should contact Meghan Locke at 781-672-3147 or mlocke@chenpr.com.
About Phase Forward
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward's products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 290 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.
A service of YellowBrix, Inc.
